LTR Pharma Executive Chairman, Lee Rodne, recently spoke with Simons Chase of Synthetic.com, taking a deep dive into the Company’s future plans to bring SPONTAN, its “first-in-class” rapid onset, on-demand therapeutic nasal spray for the treatment of erectile dysfunction (ED), to the Australian and US markets.

Take a look: